A growing body of scientific insight is drawing attention to cellular senescence as a central force in the progression of intervertebral disc degeneration (IDD), a leading contributor to chronic low back pain worldwide, according to an Aug. 5 report. This condition, which significantly impacts mobility and quality of life, is now increasingly understood through the lens of aging-related cellular changes that disrupt the delicate balance of spinal tissues.
At the core of this perspective is the role of senescent cells, which lose their ability to divide and function normally while actively releasing inflammatory and tissue-altering signals. These signals, collectively known as the senescence-associated secretory phenotype (SASP), create a harmful microenvironment that accelerates tissue breakdown and impairs repair processes. Over time, the accumulation of these dysfunctional cells contributes to structural deterioration within the spine.
The intervertebral disc, composed of the nucleus pulposus, annulus fibrosus, and cartilaginous endplates, relies on tightly regulated cellular activity to maintain flexibility and mechanical strength. As highlighted in a diagram referenced by researchers, these components work together to support spinal movement and stability. When senescence disrupts this balance, key changes emerge, including reduced elasticity, increased inflammation, and progressive tissue degeneration.
Multiple biological processes are linked to this decline. Oxidative stress, DNA damage, and mitochondrial dysfunction are among triggers that push cells into a senescent state. In response, pathways such as NF-κB, p53/p21, and PI3K/AKT/mTOR become altered—further amplifying inflammation and cellular arrest—as shown in mechanistic illustrations provided by scientists.
Importantly, the impact of cellular senescence extends across all major disc components: in the nucleus pulposus it leads to loss of structural cells; in the annulus fibrosus it weakens integrity; in cartilaginous endplates it disrupts nutrient exchange and promotes calcification.
Emerging therapeutic strategies are beginning to focus on targeting senescence itself, with approaches aimed at eliminating these cells or suppressing harmful signaling pathways being explored for their potential benefits.
